|
"chou sw"的相關文件
顯示項目 1-14 / 14 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-09 |
Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
|
Chang, YH;Yu, CH;Lu, MY;Jou, ST;Lin, CY;Lin, KH;Chang, HH;Ni, YL;Chou, SW;Ko, KY;Lin, DT;Hsu, WM;Chen, HY;Yang, YL |
| 國家衛生研究院 |
2024-04 |
Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia
|
Yu, CH;Su, YH;Jou, ST;Lu, MY;Lin, CY;Lin, KH;Chang, HH;Chou, SW;Huang, YH;Lin, DT;Lin, SW;Chen, HY;Chang, YH;Yang, YL |
| 臺大學術典藏 |
2021-11-03T01:38:37Z |
Low-toxicity FePt nanoparticles for the targeted and enhanced diagnosis of breast tumors using few centimeters deep whole-body photoacoustic imaging
|
Liu, YB; Wu, PC; Guo, S; Chou, PT; Deng, CX; Chou, SW; Yuan, Z; Liu, TM; PI-TAI CHOU |
| 臺大學術典藏 |
2021-11-03T01:38:33Z |
Boost reactivity of tri-iodide reduction electrode by highly faceted octahedral PtNi nanocrystals
|
Chou, SW; Yang, YY; Lin, CY; Goran, D; Chou, KC; Chou, PT; PI-TAI CHOU |
| 國家衛生研究院 |
2021-10-19 |
SOD2 enhancement by long-term inhibition of the pi3k pathway confers multi-drug resistance and enhanced tumor-initiating features in head and neck cancer
|
Hsueh, WT;Chen, SH;Chien, CH;Chou, SW;Chi, PI;Chu, JM;Chang, KY |
| 中山醫學大學 |
2021 |
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan
|
Yang, YL; Jaing, TH; Chen, SH; Liu, HC; Hung, IJ; Lin, DT; Yang, CP; Peng, CT; Lin, KH; Hsiao, CC; Jou, ST; Chen, JS; Lin, MT; Wang, SC; Chang, TK; Huang, FL; Cheng, CN; Wu, KH; Sheen, JM; Chen, SH; Lu, MY; Hung, GY; Yen, HJ; Hsieh, YL; Wang, JL; Chang, YH; Chang, HH; Yeh, TC; Weng, TF; Hou, JY; Chen, BW; Chen, RL; Wang, LY; Ho, WL; Chen, YC; Cheng, SN; Chao, YH; Yang, SH; Huang, TH; Chou, SW; Lin, CY; Chen, HY; Chao, YMY; Liang, DC; Chang, TT |
| 國家衛生研究院 |
2019-10-19 |
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
|
Chien, CH;Chuang, JY;Yang, ST;Yang, WB;Chen, PY;Hsu, TI;Huang, CY;Lo, WL;Yang, KY;Liu, MS;Chu, JM;Chung, PH;Liu, JJ;Chou, SW;Chen, SH;Chang, KY |
| 國家衛生研究院 |
2017-11 |
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
|
Shih, CH;Chang, YJ;Huang, WC;Jang, TH;Kung, HJ;Wang, WC;Yang, MH;Lin, MC;Huang, SF;Chou, SW;Chang, E;Chiu, H;Shieh, TY;Chen, YJ;Wang, LH;Chen, L |
| 國家衛生研究院 |
2017-08-12 |
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase
|
Chang, KY;Hsu, TI;Hsu, CC;Tsai, SY;Liu, JJ;Chou, SW;Liu, MS;Liou, JP;Ko, CY;Chen, KY;Hung, JJ;Chang, WC;Chuang, CK;Kao, TJ;Chuang, JY |
| 國家衛生研究院 |
2015-09-26 |
Anti-alpha-enolase is a prognostic marker in postoperative lung cancer patients
|
Hsiao, KC;Shih, NY;Chu, PY;Hung, YM;Liao, JY;Chou, SW;Yang, YY;Chang, GC;Liu, KJ |
| 國家衛生研究院 |
2014-05 |
Evidence-based health policy supported by science and technology research planning
|
Ho, KT;Pan, LY;Tai, CL;Chou, SW |
| 國家衛生研究院 |
2013-07-19 |
Surface alpha-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target
|
Hsiao, KC;Shih, NY;Fang, HL;Huang, TS;Kuo, CC;Chu, PY;Hung, YM;Chou, SW;Yang, YY;Chang, GC;Liu, KJ |
| 國家衛生研究院 |
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY |
顯示項目 1-14 / 14 (共1頁)
1
每頁顯示[10|25|50]項目
|
